Neuroendocrine Tumor SPORE Center

Neuroendocrine Tumor SPORE Center

Mission

The University of Iowa and the Holden Comprehensive Cancer Center houses the first and only Specialized Program of Research Excellence (SPORE) in carcinoid and neuroendocrine tumors where academic, industry, and philanthropic organizations will partner with the National Cancer Institute (NCI) to increase the length and quality of life for children and adults with these rare cancers. 

Our SPORE team welcomes patients and their families to visit our website to learn more about carcinoid and neuroendocrine tumors as well as to inquire about their particular disease process. We focus on highly individualized diagnosis and treatment. Our SPORE team also welcomes other basic scientists, clinical investigators, health care professionals and members of the health care industry to visit our site and to work with us to accomplish our mission.

UI neuroendocrine tumor program earns high European distinction

University of Iowa Holden Comprehensive Cancer Center is the first U.S. cancer center to be designated a Neuroendocrine Tumor Center of Excellence by the European Neuroendocrine Tumor Society (ENETS).


Theranostics and Nuclear Medicine

Research

Surgery

M. Sue O’Dorisio, MD, PhD
Principal Investigator, Neuroendocrine Tumor SPORE
Professor of Pediatrics and Pediatric Oncology
319-356-3595
sue-odorisio@uiowa.edu